Taro Pharmaceutical Industries Ltd (TARO)
42.28
-0.14
(-0.33%)
USD |
NYSE |
May 08, 16:00
42.32
+0.04
(+0.09%)
Pre-Market: 20:00
Taro Pharmaceutical Industries Revenue (TTM): 610.83M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 610.83M |
| September 30, 2023 | 592.88M |
| June 30, 2023 | 575.18M |
| March 31, 2023 | 572.95M |
| December 31, 2022 | 569.63M |
| September 30, 2022 | 569.41M |
| June 30, 2022 | 570.90M |
| March 31, 2022 | 561.35M |
| December 31, 2021 | 566.43M |
| September 30, 2021 | 567.59M |
| June 30, 2021 | 578.45M |
| March 31, 2021 | 548.97M |
| December 31, 2020 | 575.56M |
| September 30, 2020 | 583.10M |
| June 30, 2020 | 601.11M |
| March 31, 2020 | 644.77M |
| December 31, 2019 | 649.75M |
| September 30, 2019 | 678.45M |
| June 30, 2019 | 676.57M |
| March 31, 2019 | 669.89M |
| December 31, 2018 | 665.19M |
| September 30, 2018 | 644.27M |
| June 30, 2018 | 655.21M |
| March 31, 2018 | 661.91M |
| December 31, 2017 | 683.11M |
| Date | Value |
|---|---|
| September 30, 2017 | 748.04M |
| June 30, 2017 | 806.92M |
| March 31, 2017 | 879.39M |
| December 31, 2016 | 948.05M |
| September 30, 2016 | 985.99M |
| June 30, 2016 | 969.26M |
| March 31, 2016 | 950.75M |
| December 31, 2015 | 929.86M |
| September 30, 2015 | 909.22M |
| June 30, 2015 | 947.99M |
| March 31, 2015 | 862.94M |
| December 31, 2014 | 805.94M |
| September 30, 2014 | 781.84M |
| June 30, 2014 | 736.32M |
| March 31, 2014 | 759.28M |
| December 31, 2013 | 737.24M |
| September 30, 2013 | 709.34M |
| June 30, 2013 | 665.00M |
| March 31, 2013 | 670.95M |
| December 31, 2012 | 650.96M |
| September 30, 2012 | 613.37M |
| June 30, 2012 | 590.65M |
| March 31, 2012 | 543.08M |
| December 31, 2011 | 505.67M |
| September 30, 2011 | 460.22M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
548.97M
Minimum
Mar 2021
678.45M
Maximum
Sep 2019
594.41M
Average
575.56M
Median
Dec 2020
Revenue (TTM) Benchmarks
| InspireMD Inc | 6.205M |
| BiomX Inc | -- |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | 0.357M |
| Holdco Nuvo Group DG Ltd | -- |